IPO Price History
Closed
Senores Pharmaceuticals Limited logo

Senores Pharmaceuticals Limited IPO

Mainboard IPOListedSENORESNSE
Current Market Price (CMP)
₹1,215.30(+210.82%)
Current Price (CMP)
₹1,215.30(+210.82%)

Live Market Quote

Listing Price & Gain
₹600(+53.45%)

Day 1 Exchange Open

IPO Issue Price
₹391

Band: ₹372 - ₹391

Total Subscription
93.69x

Overall Bid Demand

Total Issue Size
—

Gross Public Offer

IPO Schedule & Key Dates

IPO Bidding Opens
20 Dec 2024
IPO Bidding Closes
24 Dec 2024
Allotment & Refunds
Completed
Exchange Listing Day
30 Dec 2024

IPO Subscription Status

Breakdown of institutional, high-net-worth, and retail bidding demand

Overall Demand: 93.69x
Investor CategorySubscriptionDemand Scale
Qualified Institutional Buyers (QIB)94.66x
Non-Institutional Investors (NII / HNI)96.3x
Retail Individual Investors (RII)90.46x
Employees Reservation20.21x
Total Subscription93.69x
Updated as on 24-Dec-2024 19:00:00

Listing Day & Return Performance

Listing Day Gain+53.45%
₹391 (Issue) → ₹600 (List)
Per share profit: +₹209.00
Holding Return (Till Date)+210.82%
₹391 (Issue) → ₹1,215.30 (CMP)
Net gain per share: +₹824.30
Post-Listing Performance (Listing Day → Today):+102.55%

About Senores Pharmaceuticals Limited IPO

Senores Pharmaceuticals Limited is an Indian public offering categorized under the Mainboard segment. The public issue opened for bidding on 20 Dec 2024 and concluded on 24 Dec 2024, offering equity shares to institutional, non-institutional, and retail investors with an indicative price band of ₹372 - ₹391.

During the bidding window, Senores Pharmaceuticals Limited witnessed heavy demand with an overall subscription of 93.69 times. Institutional investors (QIB) subscribed 94.66x, non-institutional high-net-worth investors (NII) subscribed 96.3x, and retail individual investors (RII) bid 90.46x their reserved quota, alongside employee participation of 20.21x.

The equity shares of Senores Pharmaceuticals Limited officially debuted on the stock exchanges on 30 Dec 2024 at an opening listing price of ₹600, delivering a listing day return of +53.45% (premium) over the final issue price. As per the latest market data, the stock trades at ₹1,215.30, representing an overall gain of +210.82% since its IPO allotment.

Frequently Asked Questions

What was the issue price or price band of Senores Pharmaceuticals Limited IPO?
The issue price of Senores Pharmaceuticals Limited IPO was fixed at ₹391 per equity share. The indicative bidding price band was ₹372 - ₹391.
What were the open, close, and listing dates for Senores Pharmaceuticals Limited IPO?
Senores Pharmaceuticals Limited IPO opened on 20 Dec 2024, closed on 24 Dec 2024, listed on 30 Dec 2024.
How much was Senores Pharmaceuticals Limited IPO subscribed?
The IPO received an overall subscription of 93.69 times. Category-wise, QIBs subscribed 94.66x, NIIs subscribed 96.3x, and Retail investors subscribed 90.46x.
What was the listing price and listing gain of Senores Pharmaceuticals Limited IPO?
Senores Pharmaceuticals Limited IPO listed on the stock exchange at ₹600, delivering a listing gain of 53.45% compared to the IPO issue price of ₹391.
Is Senores Pharmaceuticals Limited IPO a Mainboard or SME IPO?
Senores Pharmaceuticals Limited IPO is a Mainboard IPO listed on the main exchange of NSE.
What is the current return of Senores Pharmaceuticals Limited IPO since its IPO?
At the latest market quote of ₹1,215.30, Senores Pharmaceuticals Limited IPO has generated an all-time return of +210.82% since its initial public offering.

Related Mainboard IPOs (2024)

UNIMECH
Unimech Aerospace and Manufacturing Limited
₹785+85.99%
VENTIVE
Ventive Hospitality Limited
₹643+11.35%
CARRARO
Carraro India Limited
₹704-7.53%
MAMATA
Mamata Machinery Limited
₹243+146.91%